# Gastrointestinal Agents: Hepatic Encephalopathy

## LENGTH OF AUTHORIZATIONS

365 Days

## PRIOR AUTHORIZATION CRITERIA

Is there any reason the patient cannot be changed to a medication not requiring prior approval?

Acceptable reasons include:

- Allergy to medication not requiring prior approval

- Contraindication to or drug interaction with medication not requiring prior approval

- History of unacceptable/toxic side effects to medication not requiring prior approval

## STEP THERAPY

all agents listed

1. For a drug requiring step therapy, there must have been inadequate clinical response to a preferred alternative
2. XIFAXAN requires a diagnosis of hepatic encephalopathy and may be approved for monotherapy or add on therapy if there has been a therapeutic failure (defined as a recurrent episode) while on lactulose

## Hepatic Encephalopathy

| Gastrointestinal Agents: Hepatic Encephalopathy  |                |
|--------------------------------------------------|----------------|
| PREFERRED                                        | NON-PREFERRED  |
| Lactulose                                        |                |
| Xifaxan ST                                       |                |

### Link to Criteria

[Gastrointestinal Agents: Hepatic Encephalopathy](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=60)
